Novel imaging biomarkers of rectal cancer aggressiveness
- Prosjektnummer
- 2015048
- Ansvarlig person
- Kathrine Røe Redalen
- Institusjon
- Akershus universitetssykehus HF
- Prosjektkategori
- Doktorgradsstipend
- Helsekategori
- Cancer
- Forskningsaktivitet
- 4. Detection and Diagnosis
NEI
Comparison of Intravoxel incoherent motion imaging and multiecho dynamic contrast-based MRI in rectal cancer.
J Magn Reson Imaging 2019 Oct;50(4):1114-1124. Epub 2019 apr 4
PMID: 30945379 - Inngår i doktorgradsavhandlingen
Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer.
Br J Cancer 2018 May;118(10):1322-1328. Epub 2018 apr 26
PMID: 29695770
Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival.
Acta Oncol 2017 Jun;56(6):813-818. Epub 2017 feb 17
PMID: 28464745 - Inngår i doktorgradsavhandlingen
Use of non-invasive imaging to monitor response to aflibercept treatment in murine models of colorectal cancer liver metastases.
Clin Exp Metastasis 2017 01;34(1):51-62. Epub 2016 nov 3
PMID: 27812769
High tumor glycine concentration is an adverse prognostic factor in locally advanced rectal cancer.
Radiother Oncol 2016 Feb;118(2):393-8. Epub 2015 des 17
PMID: 26705680
Personalized radiotherapy: concepts, biomarkers and trial design.
Br J Radiol 2015 Jul;88(1051):20150009. Epub 2015 mai 20
PMID: 25989697
MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer.
Br J Radiol 2015 Jul;88(1051):20150097. Epub 2015 apr 22
PMID: 25899892
Tumour perfusion estimated from diffusion-weighted MRI of rectal cancer – an indirect marker of tumour hypoxia?
The 8th National PhD Conference in Medical Imaging; 2016
Histogram analysis of ADCs from DWMRI predicts tumour response and survival for rectal cancer
35th annual meeting of the European Society for Radiotherapy & Oncology (ESTRO); 2016
Diffusion-weighted MRI can predict response to aflibercept in in vivo models
American Association for Cancer Research (AACR) Annual Meeting; 2016
Vil lage mer tilpasset behandling for endetarmskreft
forskning.no, 6. oktober 2016
Assessing cancer aggressiveness by functional magnetic resonance imaging
- Disputert:
- desember 2019
- Hovedveileder:
- Kathrine Røe Redalen
- Atle Bjørnerud Medveileder
- Therese Seierstad Medveileder
- Anne Hansen Ree Forskningsgruppeleder
- Stein Harald Holmedal Prosjektdeltaker
- Anne Negard Prosjektdeltaker
- Lars Gustav Lyckander Prosjektdeltaker
- Tryggve Storås Prosjektdeltaker
- Endre Grøvik Prosjektdeltaker
- Kjell-Inge Gjesdal Prosjektdeltaker
- Sebastian Meltzer Prosjektdeltaker
- Kathrine Røe Redalen Prosjektleder
- Kine Mari Bakke Doktorgradsstipendiat (finansiert av denne bevilgning)
- Krystyna Kotanska-grøholt Prosjektdeltaker
- Svein Dueland Prosjektdeltaker
- Kjersti Flatmark Prosjektdeltaker
- Knut Håkon Hole Prosjektdeltaker
- Arne Sigmund Borthne Prosjektdeltaker
- Hanna Abrahamsson Prosjektdeltaker
- Christin Johansen Prosjektdeltaker
- Marius Bornstein Prosjektdeltaker
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport